NCT00083148View on ClinicalTrials.gov

Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

March 31, 2005

Study Completion Date

September 30, 2006

Conditions
Breast Cancer
Interventions
DRUG

capecitabine

DRUG

irinotecan hydrochloride

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00083148 - Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer | Biotech Hunter | Biotech Hunter